Medical Device & Digital Health Conference
MDC 2026Thursday, June 4 & Friday, June 5
InterContinental888 Howard St.San Francisco, CA
Wilson Sonsini’s 33rd Annual Medical Device & Digital Health Conference will address topics of critical importance to medical device and digital health companies.
Join us for our 2026 event, which will feature engaging panel sessions and keynote addresses, a Partnering Hall where you can connect with start-ups from around the globe, the MedTech Innovator pitch event, and a festive wine tasting reception where VCs serve as sommeliers.
2025 topics discussed included:
Future of Bioelectric Medicine and Digital Health Platforms
Medtech & Digital Health by the Numbers
Patent Strategies for Emerging Commercial Growth Companies
Early Medtech Investing
Strategic Investments in Medtech
Regulatory Updates: U.S. Food and Drug Administration (FDA) & Navigating Regulatory Uncertainties and the Need for Early Evidence Generation
At the Intersection of Digital Health and Medical Devices
Medtech M&A: Trends and Strategies for Successfully Navigating the Current Market
The Current Status of Medtech Innovation
Learn from Wilson Sonsini: Digital Health Regulatory Legal Updates
The Private Company Compensation Playbook
AI Trends in Healthcare
Latest and Greatest on Equity Compensation
Stanford Biodesign: Training the Future Leaders of Healthcare Innovation
Late-Stage Venture Capital Investments
Commercialization Strategies for Medical Device and Digital Health Companies
Navigating Antitrust Challenges in Business Exits: Strategies for Success
Leadership at the Forefront: A Dialogue with Digital Health CEOs, Founders, and Investors
MDC 2024 Highlight
“I’ve been attending the annual Wilson Sonsini Medical Device and Digital Health Conference now for about thirteen years, and I look forward to seeing my peers and people from all over the ecosystem that I know I can look forward to being here. Most importantly, I know that our startups who are coming in from all over the world are going to have access to some of the top investors and some of the other clinicians and people who are supporting these companies.”
– Paul Grand, MedTech Innovator
